Daxor Corp
NASDAQ:DXR

Watchlist Manager
Daxor Corp Logo
Daxor Corp
NASDAQ:DXR
Watchlist
Price: 9.1325 USD 4.25% Market Closed
Market Cap: 44.2m USD
Have any thoughts about
Daxor Corp?
Write Note

Intrinsic Value

The intrinsic value of one DXR stock under the Base Case scenario is 3.2272 USD. Compared to the current market price of 9.1325 USD, Daxor Corp is Overvalued by 65%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DXR Intrinsic Value
3.2272 USD
Overvaluation 65%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Daxor Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DXR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DXR?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Daxor Corp

Provide an overview of the primary business activities
of Daxor Corp.

What unique competitive advantages
does Daxor Corp hold over its rivals?

What risks and challenges
does Daxor Corp face in the near future?

Has there been any significant insider trading activity
in Daxor Corp recently?

Summarize the latest earnings call
of Daxor Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Daxor Corp.

Provide P/S
for Daxor Corp.

Provide P/E
for Daxor Corp.

Provide P/OCF
for Daxor Corp.

Provide P/FCFE
for Daxor Corp.

Provide P/B
for Daxor Corp.

Provide EV/S
for Daxor Corp.

Provide EV/GP
for Daxor Corp.

Provide EV/EBITDA
for Daxor Corp.

Provide EV/EBIT
for Daxor Corp.

Provide EV/OCF
for Daxor Corp.

Provide EV/FCFF
for Daxor Corp.

Provide EV/IC
for Daxor Corp.

Show me price targets
for Daxor Corp made by professional analysts.

What are the Revenue projections
for Daxor Corp?

How accurate were the past Revenue estimates
for Daxor Corp?

What are the Net Income projections
for Daxor Corp?

How accurate were the past Net Income estimates
for Daxor Corp?

What are the EPS projections
for Daxor Corp?

How accurate were the past EPS estimates
for Daxor Corp?

What are the EBIT projections
for Daxor Corp?

How accurate were the past EBIT estimates
for Daxor Corp?

Compare the revenue forecasts
for Daxor Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Daxor Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Daxor Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Daxor Corp compared to its peers.

Compare the P/E ratios
of Daxor Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Daxor Corp with its peers.

Analyze the financial leverage
of Daxor Corp compared to its main competitors.

Show all profitability ratios
for Daxor Corp.

Provide ROE
for Daxor Corp.

Provide ROA
for Daxor Corp.

Provide ROIC
for Daxor Corp.

Provide ROCE
for Daxor Corp.

Provide Gross Margin
for Daxor Corp.

Provide Operating Margin
for Daxor Corp.

Provide Net Margin
for Daxor Corp.

Provide FCF Margin
for Daxor Corp.

Show all solvency ratios
for Daxor Corp.

Provide D/E Ratio
for Daxor Corp.

Provide D/A Ratio
for Daxor Corp.

Provide Interest Coverage Ratio
for Daxor Corp.

Provide Altman Z-Score Ratio
for Daxor Corp.

Provide Quick Ratio
for Daxor Corp.

Provide Current Ratio
for Daxor Corp.

Provide Cash Ratio
for Daxor Corp.

What is the historical Revenue growth
over the last 5 years for Daxor Corp?

What is the historical Net Income growth
over the last 5 years for Daxor Corp?

What is the current Free Cash Flow
of Daxor Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Daxor Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Daxor Corp

Current Assets 20.1k
Receivables 20.1k
Non-Current Assets 34.4m
Long-Term Investments 34.4m
Other Non-Current Assets 10
Current Liabilities 1.7m
Accrued Liabilities 70.6k
Short-Term Debt 1.6m
Efficiency

Earnings Waterfall
Daxor Corp

Revenue
154.2k USD
Cost of Revenue
-745.1k USD
Gross Profit
-590.9k USD
Operating Expenses
-225k USD
Operating Income
-815.8k USD
Other Expenses
2.5m USD
Net Income
1.7m USD

Free Cash Flow Analysis
Daxor Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DXR Profitability Score
Profitability Due Diligence

Daxor Corp's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Positive Net Income
Positive 3-Year Average ROE
ROE is Increasing
ROIC is Increasing
34/100
Profitability
Score

Daxor Corp's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

DXR Solvency Score
Solvency Due Diligence

Daxor Corp's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
54/100
Solvency
Score

Daxor Corp's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DXR Price Targets Summary
Daxor Corp

Wall Street analysts forecast DXR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXR is 23.8425 USD with a low forecast of 22.22 USD and a high forecast of 25.9875 USD.

Lowest
Price Target
22.22 USD
143% Upside
Average
Price Target
23.8425 USD
161% Upside
Highest
Price Target
25.9875 USD
185% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DXR?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DXR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

DXR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Daxor Corp Logo
Daxor Corp

Country

United States of America

Industry

Health Care

Market Cap

44.2m USD

Dividend Yield

0%

Description

Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. The company is headquartered in New York City, New York. The Company’s investment objectives are capital preservation, maintaining returns on capital with a high degree of safety and generating income from dividends and option sales to help offset operating losses from the Company’s operating division. The firm intends to maintain a diversified securities portfolio comprised primarily of electric utility company common and preferred stocks. The firm seeks to maintain a minimum of 80% of its portfolio in equity securities of utility companies.

Contact

NEW YORK
New York City
350 5th Ave Ste 4740
+12123308500.0
www.daxor.com

IPO

1983-07-25

Employees

-

Officers

Chief Scientific Officer & Director
Mr. Jonathan Adam Feldschuh
Chairman, President & CEO
Mr. Michael Richard Feldschuh
CFO, Chief Compliance Officer & Corporate Secretary
Mr. Robert J. Michel CPA, CPA, M.B.A.
Vice President of Development & Operations
Ms. Linda Cooper
Senior VP of Marketing & Commercial Development
Ms. Kathryn A. Kornafel
Vice President of Sales
Mr. Guido Manzo
Show More
Senior Vice President Commercialization & Customer Experience
Ms. Jean Oertel
Chief Medical Officer
Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H.
Show Less

See Also

Discover More
What is the Intrinsic Value of one DXR stock?

The intrinsic value of one DXR stock under the Base Case scenario is 3.2272 USD.

Is DXR stock undervalued or overvalued?

Compared to the current market price of 9.1325 USD, Daxor Corp is Overvalued by 65%.

Back to Top